
Spatz FGIA
Adjustable gastric balloon system enhancing weight loss results and improving food attitudes.
Date | Investors | Amount | Round |
---|---|---|---|
$1.6m | Series C | ||
Total Funding | 000k |
Related Content
Spatz Medical specializes in the development and distribution of the Spatz3 adjustable gastric balloon system, designed to aid in weight loss and promote healthier attitudes towards food. The company primarily serves individuals seeking effective weight loss solutions, operating within the global healthcare and medical devices market. Spatz Medical's business model revolves around the sale and support of its proprietary gastric balloon system, which features unique volume adjustment capabilities to optimize weight loss results and manage balloon intolerance. Revenue is generated through direct sales to consumers and partnerships with medical professionals and clinics worldwide.
Keywords: adjustable gastric balloon, weight loss, healthcare, medical devices, volume adjustment, food attitudes, global market, proprietary system, revenue generation, medical partnerships.